Liver transplantation for acute hepatic failure?

Area of Science:

• Hepatology
• Transplantation Medicine
• Critical Care

Background:

• Fulminant hepatic failure (FHF) lacks definitive medical treatments, making liver transplantation a potential option for select patients.
• Current criteria for FHF severity and treatment outcomes are not standardized, leading to concerns about unnecessary transplants and undertreatment of eligible patients.
• Historical treatment regimens for FHF have often lacked robust evidence, with controlled trials failing to demonstrate benefit.

Purpose of the Study:

• To highlight the need for uniform and applicable criteria for diagnosing FHF severity.
• To emphasize the necessity of standardized methods for analyzing outcomes in FHF patients undergoing liver transplantation.
• To advocate for a controlled trial to rapidly establish the role and efficacy of emergency hepatic transplantation in FHF.

Main Methods:

• Review of existing literature and clinical practices regarding FHF management and liver transplantation.
• Identification of limitations in current diagnostic and prognostic criteria for FHF.
• Proposal for a multi-center controlled trial involving specialist liver transplant units.

Main Results:

• Lack of standardized criteria hinders optimal patient selection for liver transplantation in FHF.
• Previous treatment approaches for FHF, based on historical data, have not been substantiated by controlled trials.
• A need exists for rapid acquisition of reliable data on the effectiveness of emergency hepatic transplantation.

Conclusions:

• Standardized criteria for FHF severity and transplant outcomes are crucial for appropriate patient management.
• Controlled trials are essential to overcome the limitations of historical data and establish evidence-based treatment strategies.
• A collaborative, controlled trial is urgently required to define the role of emergency hepatic transplantation in FHF.